Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

pembrolizumab 4Magnetic Resonance Spectroscopy 4Radiotherapy 3Nivolumab 3Cetuximab 3fluoromisonidazole 2durvalumab 2Neoadjuvant Therapy 2Metformin 2Immunohistochemistry 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Cisplatin 2sitravatinib 1ruxolitinib 1ribociclib 1fluciclovine F-18 1dornase alfa 1avelumab 1antitumor A 1alovudine 1Varenicline 1Valproic Acid 1VTX-2337 1TAK-981 1Surgical Procedures, Operative 1Raltegravir Potassium 1Radiotherapy, Intensity-Modulated 1Plastic Surgery Procedures 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Squamous Cell Carcinoma of Head and Neck × C188-9 compound × Clear all
NCT05845307 2025-12-08

Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡